Histiocytic Sarcoma: Malignant neoplasms composed of MACROPHAGES or DENDRITIC CELLS. Most histiocytic sarcomas present as localized tumor masses without a leukemic phase. Though the biological behavior of these neoplasms resemble lymphomas, their cell lineage is histiocytic not lymphoid.Histiocytic Disorders, Malignant: Distinctive neoplastic disorders of histiocytes. Included are malignant neoplasms of MACROPHAGES and DENDRITIC CELLS.Sarcoma: A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.Histiocytes: Macrophages found in the TISSUES, as opposed to those found in the blood (MONOCYTES) or serous cavities (SEROUS MEMBRANE).Hyalin: A clear, homogenous, structureless, eosinophilic substance occurring in pathological degeneration of tissues.Splenic Neoplasms: Tumors or cancer of the SPLEEN.Dog Diseases: Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used.Sarcoma, Experimental: Experimentally induced neoplasms of CONNECTIVE TISSUE in animals to provide a model for studying human SARCOMA.Antigens, Differentiation, Myelomonocytic: Surface antigens expressed on myeloid cells of the granulocyte-monocyte-histiocyte series during differentiation. Analysis of their reactivity in normal and malignant myelomonocytic cells is useful in identifying and classifying human leukemias and lymphomas.Dogs: The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)Muramidase: A basic enzyme that is present in saliva, tears, egg white, and many animal fluids. It functions as an antibacterial agent. The enzyme catalyzes the hydrolysis of 1,4-beta-linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. EC 3.2.1.17.Sarcoma, Ewing: A malignant tumor of the bone which always arises in the medullary tissue, occurring more often in cylindrical bones. The tumor occurs usually before the age of 20, about twice as frequently in males as in females.Sarcoma, Synovial: A malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic (characterized by sheaths of monotonous spindle cells) and the biphasic (characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells). These sarcomas occur most commonly in the second and fourth decades of life. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1363)Sarcoma, Kaposi: A multicentric, malignant neoplastic vascular proliferation characterized by the development of bluish-red cutaneous nodules, usually on the lower extremities, most often on the toes or feet, and slowly increasing in size and number and spreading to more proximal areas. The tumors have endothelium-lined channels and vascular spaces admixed with variably sized aggregates of spindle-shaped cells, and often remain confined to the skin and subcutaneous tissue, but widespread visceral involvement may occur. Kaposi's sarcoma occurs spontaneously in Jewish and Italian males in Europe and the United States. An aggressive variant in young children is endemic in some areas of Africa. A third form occurs in about 0.04% of kidney transplant patients. There is also a high incidence in AIDS patients. (From Dorland, 27th ed & Holland et al., Cancer Medicine, 3d ed, pp2105-7) HHV-8 is the suspected cause.Histiocytosis, Langerhans-Cell: A group of disorders resulting from the abnormal proliferation of and tissue infiltration by LANGERHANS CELLS which can be detected by their characteristic Birbeck granules (X bodies), or by monoclonal antibody staining for their surface CD1 ANTIGENS. Langerhans-cell granulomatosis can involve a single organ, or can be a systemic disorder.Lymphatic Diseases: Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS.Histiocytosis: General term for the abnormal appearance of histiocytes in the blood. Based on the pathological features of the cells involved rather than on clinical findings, the histiocytic diseases are subdivided into three groups: HISTIOCYTOSIS, LANGERHANS CELL; HISTIOCYTOSIS, NON-LANGERHANS-CELL; and HISTIOCYTIC DISORDERS, MALIGNANT.Encyclopedias as Topic: Works containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. (From The ALA Glossary of Library and Information Science, 1983)Langerhans Cells: Recirculating, dendritic, antigen-presenting cells containing characteristic racket-shaped granules (Birbeck granules). They are found principally in the stratum spinosum of the EPIDERMIS and are rich in Class II MAJOR HISTOCOMPATIBILITY COMPLEX molecules. Langerhans cells were the first dendritic cell to be described and have been a model of study for other dendritic cells (DCs), especially other migrating DCs such as dermal DCs and INTERSTITIAL DENDRITIC CELLS.PubMed: A bibliographic database that includes MEDLINE as its primary subset. It is produced by the National Center for Biotechnology Information (NCBI), part of the NATIONAL LIBRARY OF MEDICINE. PubMed, which is searchable through NLM's Web site, also includes access to additional citations to selected life sciences journals not in MEDLINE, and links to other resources such as the full-text of articles at participating publishers' Web sites, NCBI's molecular biology databases, and PubMed Central.Periodicals as Topic: A publication issued at stated, more or less regular, intervals.BooksPublishing: "The business or profession of the commercial production and issuance of literature" (Webster's 3d). It includes the publisher, publication processes, editing and editors. Production may be by conventional printing methods or by electronic publishing.MEDLINE: The premier bibliographic database of the NATIONAL LIBRARY OF MEDICINE. MEDLINE® (MEDLARS Online) is the primary subset of PUBMED and can be searched on NLM's Web site in PubMed or the NLM Gateway. MEDLINE references are indexed with MEDICAL SUBJECT HEADINGS (MeSH).Serial Publications: Publications in any medium issued in successive parts bearing numerical or chronological designations and intended to be continued indefinitely. (ALA Glossary of Library and Information Science, 1983, p203)Biological Science Disciplines: All of the divisions of the natural sciences dealing with the various aspects of the phenomena of life and vital processes. The concept includes anatomy and physiology, biochemistry and biophysics, and the biology of animals, plants, and microorganisms. It should be differentiated from BIOLOGY, one of its subdivisions, concerned specifically with the origin and life processes of living organisms.Histiocytoma, Benign Fibrous: A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 5th ed, p1747)Histiocytoma, Malignant Fibrous: The most commonly diagnosed soft tissue sarcoma. It is a neoplasm with a fibrohistiocytic appearance found chiefly in later adult life, with peak incidence in the 7th decade.Dictionaries, MedicalErythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of causes.Dictionaries as Topic: Lists of words, usually in alphabetical order, giving information about form, pronunciation, etymology, grammar, and meaning.Erythema Nodosum: An erythematous eruption commonly associated with drug reactions or infection and characterized by inflammatory nodules that are usually tender, multiple, and bilateral. These nodules are located predominantly on the shins with less common occurrence on the thighs and forearms. They undergo characteristic color changes ending in temporary bruise-like areas. This condition usually subsides in 3-6 weeks without scarring or atrophy.Dictionaries, ChemicalTerminology as Topic: The terms, expressions, designations, or symbols used in a particular science, discipline, or specialized subject area.Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.Immune System: The body's defense mechanism against foreign organisms or substances and deviant native cells. It includes the humoral immune response and the cell-mediated response and consists of a complex of interrelated cellular, molecular, and genetic components.B-Lymphocytes: Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.Lymphoma, T-Cell: A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.Histocompatibility Antigens Class I: Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells.Lymphocyte Cooperation: T-cell enhancement of the B-cell response to thymic-dependent antigens.Laser Therapy: The use of photothermal effects of LASERS to coagulate, incise, vaporize, resect, dissect, or resurface tissue.Electronic Mail: Messages between computer users via COMPUTER COMMUNICATION NETWORKS. This feature duplicates most of the features of paper mail, such as forwarding, multiple copies, and attachments of images and other file types, but with a speed advantage. The term also refers to an individual message sent in this way.Rh-Hr Blood-Group System: Erythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups. The major antigen Rh or D is the most common cause of erythroblastosis fetalis.National Library of Medicine (U.S.): An agency of the NATIONAL INSTITUTES OF HEALTH concerned with overall planning, promoting, and administering programs pertaining to advancement of medical and related sciences. Major activities of this institute include the collection, dissemination, and exchange of information important to the progress of medicine and health, research in medical informatics and support for medical library development.Internet: A loose confederation of computer communication networks around the world. The networks that make up the Internet are connected through several backbone networks. The Internet grew out of the US Government ARPAnet project and was designed to facilitate information exchange.Antigens, CD8: Differentiation antigens found on thymocytes and on cytotoxic and suppressor T-lymphocytes. CD8 antigens are members of the immunoglobulin supergene family and are associative recognition elements in MHC (Major Histocompatibility Complex) Class I-restricted interactions.Antigens, CD3: Complex of at least five membrane-bound polypeptides in mature T-lymphocytes that are non-covalently associated with one another and with the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL). The CD3 complex includes the gamma, delta, epsilon, zeta, and eta chains (subunits). When antigen binds to the T-cell receptor, the CD3 complex transduces the activating signals to the cytoplasm of the T-cell. The CD3 gamma and delta chains (subunits) are separate from and not related to the gamma/delta chains of the T-cell receptor (RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA).Lymphoma, Large B-Cell, Diffuse: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.Lymphoma, B-Cell: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.Bone Marrow: The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells.Proto-Oncogene Proteins c-bcl-6: A DNA-binding protein that represses GENETIC TRANSCRIPTION of target genes by recruiting HISTONE DEACETYLASES. Aberrant Blc-6 expression is associated with certain types of human B-CELL LYMPHOMA.Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.Lymphoma, Follicular: Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the LYMPH NODES. The nodules resemble to some extent the GERMINAL CENTER of lymph node follicles and most likely represent neoplastic proliferation of lymph node-derived follicular center B-LYMPHOCYTES.Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
... with diffuse histiocytic sarcoma". Front Microbiol. 5: 655. doi:10.3389/fmicb.2014.00655. Fonseca, Eduardo K.U.N. (January 2018 ... For example, a candidate parvovirus has recently been isolated by sequencing a histocytic sarcoma in a slow loris (Nycticebus ... coucang). The relationship between the virus and the sarcoma was not clear. Proposed additional genera include Chapparvovirus ...
Bernese Mountain Dogs Diffuse histiocytic sarcoma Localized histiocytic sarcoma Malignant diseases of macrophages Histiocytic ... Histiocytoma from The Pet Health Library Histiocytoma and Histiocytic Sarcoma in Cats and Dogs from Pet Cancer Center Photos of ... Histiocytic disorders refer to diseases that are caused by abnormal behavior of these cells. They include the following: ... "Tumors with Histiocytic Differentiation". The Merck Veterinary Manual. 2006. Retrieved 2007-04-29. Ginhoux F, Tacke F, Angeli V ...
... Diffuse histiocytic sarcoma Localized histiocytic sarcoma Malignant diseases of macrophages Histiocytic ... A similar disease is diffuse histiocytic sarcoma, a term used to designate a localized histiocytic sarcoma that has spread ... Affolter V, Moore P (2002). "Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs". Vet Pathol. 39 ( ... Histiocytic sarcoma complex (immunohistochemical features of dendritic cells, possibly interdigitating or perivascular DCs) ...
Histiocytic sarcoma Localized histiocytic sarcoma diffuse histiocytic sarcoma Histiocytoma is a common, benign, cutaneous ... Histiocytic neoplasia which originates at a single site is called histiocytic sarcoma. This form of histiocytic sarcoma, which ... The histiocytic sarcoma (HS) complex encompasses a number of distinctive clinical entities which will be described below. Some ... Pathologists diagnosed histiocytic sarcoma in these instances and prognosis was reported as poor. In 3 instances regression of ...
Diffuse large B-cell lymphoma (primary cutaneous large B-cell lymphoma) Granulocytic sarcoma (chloroma, myeloid sarcoma) ... histiocytic medullary reticulosis) Marginal zone B-cell lymphoma Mucosa-associated lymphoid tissue lymphoma Mycosis fungoides ... diffuse non-epidermolytic palmoplantar keratoderma with woolly hair and cardiomyopathy, diffuse palmoplantar keratoderma with ... African lymphadenopathic Kaposi sarcoma Aggressive infantile fibromatosis AIDS-associated Kaposi sarcoma Ainhum (bankokerend, ...
... diffuse MeSH C15.604.515.569.480.300.300 --- lymphoma, large-cell, diffuse MeSH C15.604.515.569.480.300.450 --- lymphoma, large ... mast-cell sarcoma MeSH C15.604.744.293 --- hypersplenism MeSH C15.604.744.428 --- myeloid metaplasia MeSH C15.604.744.617 --- ... histiocytic disorders, malignant MeSH C15.604.667.400.390.400 --- histiocytosis, malignant MeSH C15.604.667.400.390.500 --- ... diffuse MeSH C15.604.515.569.480.300.725 --- lymphoma, small cleaved-cell, diffuse MeSH C15.604.515.569.480.300.725.500 --- ...
... diffuse) (C83.1) Small cleaved cell (diffuse) (C83.2) Mixed small and large cell (diffuse) (C83.3) large cell (diffuse) (C83.4 ... Myeloid sarcoma Chloroma Granulocytic sarcoma (C92.4) Acute promyelocytic leukemia (C92.5) Acute myelomonocytic leukemia (C93) ... Histiocytic and mast cell tumours of uncertain and unknown behaviour Mast cell tumour NOS Mastocytoma NOS (D47.1) Chronic ... Immunoblastic (diffuse) (C83.5) Lymphoblastic (diffuse) (C83.6) Undifferentiated (diffuse) (C83.7) Burkitt's tumour (C84) ...
... diffuse Reticulum cell sarcoma, NOS Reticulum cell sarcoma, diffuse Reticulosarcoma, NOS Reticulosarcoma, diffuse Malignant ... X M9755/3 Histiocytic sarcoma True histiocytic lymphoma M9756/3 Langerhans cell sarcoma M9757/3 Dendritic cell sarcoma, NOS ... Pleomorphic cell sarcoma M8803/3 Small cell sarcoma Round cell sarcoma M8804/3 Epithelioid sarcoma Epithelioid cell sarcoma ... diffuse (see also M9690/3) Malignant lymphoma, mixed lymphocytic-histiocytic, diffuse Malignant lymphoma, mixed cell type, ...
Histiocytoma/histiocytic sarcoma: Benign fibrous histiocytoma · Malignant fibrous histiocytoma · Atypical fibroxanthoma ... Fibroma/fibromatosis: Aggressive infantile fibromatosis · Aponeurotic fibroma · Collagenous fibroma · Diffuse infantile ... Connective/soft tissue tumors and sarcomas (ICD-O 8800-9059) (C45-C49/D17-D21, 171/214-215) ... Clear-cell sarcoma of the kidney · Hepatoblastoma · Pancreatoblastoma · Carcinosarcoma ...
Histiocytoma/histiocytic sarcoma:. *Benign fibrous histiocytoma. *Malignant fibrous histiocytoma. *Atypical fibroxanthoma. * ... Diffuse infantile fibromatosis. *Familial myxovascular fibromas. *Fibroma of tendon sheath. *Fibromatosis colli ... see Template:Soft tissue tumors and sarcomas, Template:Vascular tumors, Template:Myeloid malignancy (for mastocytosis) ... Connective/soft tissue tumors and sarcomas (ICD-O 8800-9059) (C45-C49/D17-D21, 171/214-215) ...
Histiocytoma/histiocytic sarcoma:. *Benign fibrous histiocytoma. *Malignant fibrous histiocytoma. *Atypical fibroxanthoma. * ... Diffuse infantile fibromatosis. *Familial myxovascular fibromas. *Fibroma of tendon sheath. *Fibromatosis colli ... "botryoid sarcoma" at Dorland's Medical Dictionary *^ Rahaman, J and Cohen, CJ. Gynecologic Sarcomas. in Holland-Frei Cancer ... Sarcoma botryoides or botryoid sarcoma[1] or botryoid rhabdomyosarcoma is a subtype of embryonal rhabdomyosarcoma, that can be ...
Diffuse iris melanoma: a report of 25 cases. Ophthalmology. 2002 Aug;109(8):1553-60. 154. Naik MN, Tourani KL, Sekhar GC, ... Lymphoproliferative, Leukemic and Histiocytic Lesions of the Orbit. In: Dutta LC, ed. Modern Ophthalmology . New Delhi, India, ... Orbital Alveolar Soft Part Sarcoma. Ophthalmology. 2016 Jul;123(7):1420. 15. Aggarwal E, Mulay K, Menon V, Sundar G, Honavar SG ... Diffuse iris melanoma: a report of 25 cases. Ophthalmology. 2002;109(8):1553-60. 160. Shields CL, Honavar SG, Meadows AT, ...
组织细胞瘤(英语:Histiocytoma)/组织细胞肉瘤(英语:histiocytic sarcoma):. *良性纤维组织细胞瘤(英语:Benign fibrous histiocytoma) ... 弥漫性婴儿纤维瘤病(英语:Diffuse infantile fibromatosis) ... 肾透明细胞肉瘤(英语
... with diffuse histiocytic sarcoma". Front Microbiol. 5: 655. doi:10.3389/fmicb.2014.00655. Fonseca, Eduardo K.U.N. (January 2018 ... For example, a candidate parvovirus has recently been isolated by sequencing a histocytic sarcoma in a slow loris (Nycticebus ... coucang). The relationship between the virus and the sarcoma was not clear. Proposed additional genera include Chapparvovirus ...
A similar disease is diffuse histiocytic sarcoma, a term used to designate a localized histiocytic sarcoma that has spread ... Histiocytoma and Histiocytic Sarcoma in Cats and Dogs from Pet Cancer Center ... Affolter V, Moore P (2002). "Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs". Vet Pathol. 39 ( ... Histiocytic sarcoma complex (immunohistochemical features of dendritic cells, possibly interdigitating or perivascular DCs) * ...
Persistent viremia by a novel parvovirus in a slow loris (Nycticebus coucang) with diffuse histiocytic sarcoma. ...
Bernese Mountain Dogs Diffuse histiocytic sarcoma Localized histiocytic sarcoma Malignant diseases of macrophages Histiocytic ... Histiocytoma from The Pet Health Library Histiocytoma and Histiocytic Sarcoma in Cats and Dogs from Pet Cancer Center Photos of ... Histiocytic disorders refer to diseases that are caused by abnormal behavior of these cells. They include the following: ... "Tumors with Histiocytic Differentiation". The Merck Veterinary Manual. 2006. Retrieved 2007-04-29. Ginhoux F, Tacke F, Angeli V ...
... DIFFUSE MIXED LYMPHOCYTIC HISTIOCYTIC, Sarcoma, Reticulum Cell, LYMPHOMA SMALL LARGE CLEAVED DIFFUSE, Lymphoma, Small ... Diffuse, DIFFUSE UNDIFFER LYMPHOMA, Sarcomas, Lymphatic, Lymphomas, Diffuse Mixed-Cell, Low-Grade Lymphoma, Sarcoma, Reticulum- ... Diffuse, Lymphoma, High-Grade, Lymphomas, Mixed Lymphocytic-Histiocytic, Mixed Lymphocytic-Histiocytic Lymphomas, Sarcomas, ... Sarcoma, Germinoblastic, Reticulum-Cell Sarcomas, Mixed-Cell Lymphomas, Diffuse, Lymphoma, Intermediate Grade, Diffuse Lymphoma ...
... diffuse histiocytic lymphoma, hepatoma, and Kaposis sarcoma. Deaths of the remaining cases were due to hypertensive ... Among the autopsies on black Americans there were no cases of opportunistic infections or Kaposis sarcoma that were considered ...
My miniature schnauzer has been diagnosed with Diffuse pulmonary and mediastinal histiocytic sarcoma cancer it is in her chest ...
Histiocytic sarcoma Localized histiocytic sarcoma diffuse histiocytic sarcoma Histiocytoma is a common, benign, cutaneous ... Histiocytic neoplasia which originates at a single site is called histiocytic sarcoma. This form of histiocytic sarcoma, which ... The histiocytic sarcoma (HS) complex encompasses a number of distinctive clinical entities which will be described below. Some ... Pathologists diagnosed histiocytic sarcoma in these instances and prognosis was reported as poor. In 3 instances regression of ...
... diffuse erythema explanation free. What is diffuse erythema? Meaning of diffuse erythema medical term. What does diffuse ... Looking for online definition of diffuse erythema in the Medical Dictionary? ... diffuse hereditary gingival fibrosis. *diffuse hereditary gingival fibrosis. *Diffuse Histiocytic Lymphoma. *Diffuse ... diffuse erythema. diffuse erythema. skin redness or inflammation that is spread over a large body surface. ...
PCNSL; Primary CNS Lymphoma; Reticulum Cell Sarcoma; Diffuse Histiocytic Lymphoma; Brain Lymphoma; Cerebral Lymphoma; Primary ...
... diffuse large B cell lymphoma, plasmacytoma, and, in addition, histiocytic sarcoma (data not shown). ... The histopathologic and molecular basis for the diagnosis of histiocytic sarcoma and histiocyte-associated lymphoma of mice. ...
... is an uncommon malignant neoplasm with morphological and immunophenotypic features of histiocytic tissue. HS presents most … ... Primary histiocytic sarcoma presenting as diffuse leptomeningeal disease: case description and review of the literature. ... Primary histiocytic sarcoma presenting as diffuse leptomeningeal disease: case description and review of the literature. ... which revealed histiocytic sarcoma with grossly purulent drainage. Staging revealed diffuse leptomeningeal involvement, ...
Histiocytic sarcoma. Diffuse large B cell lymphoma (occasionally). Mantle cell lymphoma-blastoid variant ... although with diffuse staining, in contrast to the dot-like keratin staining of granulosa cell tumors (AJSP 1992;16:962). The ... differential diagnosis of granulosa cell tumors also includes endometrial stromal sarcoma, endometrioid carcinoma, small cell ...
... of diffuse large B cell lymphoma (DLBCL) cases, bone marrow (BM), assessed by BM biopsy, is involved. BM involvement, an ... Trametinib and Dabrafenib in histiocytic sarcoma transdifferentiated from chronic lymphocytic leukemia with a K-RAS and a ... In 27% of diffuse large B cell lymphoma (DLBCL) cases, bone marrow (BM), assessed by BM biopsy, is involved. BM involvement, an ... Poor prognosis in patients with diffuse large B cell lymphomas with bone marrow involvement possessing chromosomal ...
Diffuse cellular foci of invasive proliferation were mainly observed in the peri/intra vascular area, sinus and serous membrane ... We report a case of histiocytic sarcoma in 11-year-old male cynomolgus macaque fed with a high-fat diet for 6 years. Invasive ... Histiocytic Sarcoma in a Cynomolgus Macaque (Macaca fascicularis) Fed with a High-Fat Diet ... Histiocytic sarcoma is characterized by a malignant invasive proliferation of atypical cells showing morphologic and ...
Primary central nervous system lymphoma (pcnsl) has been known by many other names, including reticulum cell sarcoma, diffuse ... histiocytic. Uncommonly, primary CNS lymphoma (pcnsl) can present as longitudinally extensive transverse myelopathy (letm). ...
Primary central nervous system lymphoma (PCNSL) has been known by many other names, including reticulum cell sarcoma, diffuse ... histiocytic lymphoma, and microglioma. The proliferation of names reflects initial uncertainty about the cell of origin. PCNSL ... More diffuse cognitive and MRI abnormalities suggest the possibility of some infectious encephalitic process such as herpes ... This is the same herpes virus that is associated with Kaposi sarcoma and with primary effusion (ie, body-cavity-based lymphomas ...
... of follicular lymphoma with transformation to diffuse large B-cell lymphoma and transdifferentiation to histiocytic sarcoma ...
... and histiocytic sarcoma (see Figure 3, g-i, for representative images of DLCL in a beclin 1+/- mouse). Both beclin 1+/- and ... including diffuse large-cell lymphoma (DLCL), follicular lymphoma, the immunoblastic variant of DLCL (DLCL-IB), anaplastic ... LC3 and its yeast homolog Apg8/Aut7p have a diffuse cytoplasmic distribution. Upon stimulation of autophagy, LC3 and Apg8/Aut7p ... diffuse large-cell lymphoma (DLCL); immunoblastic DLCL (DLCL-IB); terminal end bud (TEB). ...
... diffuse histiocytic lymphoma, and granulocytic sarcoma, have sometimes been shown to carry the PICALM-MLLT10 fusion gene (alias ... Three out of four therapy-related PICALM-MLLT10 AMLs had been previously treated for diffuse large B-cell lymphoma. The ...
underlying systemic diseases which included Hodgkins disease (3), reticulum cell sarcoma (1), diffuse histiocytic lymphoma (1 ... Microscopically, neutrophilic infiltrates, diffuse edema, and microabscesses may be seen, which may coalesce into larger ...
... histiocytic sarcoma, diffuse large B-cell lymphoma, atypical fibroxanthoma, benign fibrous histiocytoma, nodular fascitis ˤ Ƥ ... Epitheloid sarcoma. A sarcoma simulating a granuloma or a carcinoma. Cancer.1970 Nov;26(5):1029-41. *2 Guillou L, et al ... A sarcoma simulating a granuloma or a carcinoma. Cancer. 1970 Nov;26(5):1029-41. *9 Fisher C. Epithelioid sarcoma of Enzinger. ... Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the French sarcoma group. Am J Clin ...
Histiocytic sarcoma is rare and difficult to distinguish from histologic mimics such as myeloid sarcoma due to its relatively ... Composite diffuse large B-cell lymphomas (DLBCLs) with peripheral T-cell lymphomas (PTCLs) are rare co-occurrences with poorly ... Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma. Human pathology ... A subset of histiocytic sarcomas are clonally related to synchronous or metachronous follicular lymphomas. Interestingly, the ...
... periarticular HS CNS HS Dendritic cell leukemia Histiocytic sarcoma complex - distinctive syndromes There are several ... If diffuse splenomegaly and discrete masses are present, immunophenotypic investigation will reveal both types of histiocytic ... Central Nervous System Histiocytic Sarcoma. The central nervous system may be infiltrated by HS as a primary location or as a ... Articular / periarticular histiocytic sarcoma. Articular HS is a localized form of HS, which occurs on the limbs. The lesions ...
Diffuse large B-cell lymphoma of the central nervous system. Histiocytic tumors. Histiocytic sarcoma. ... aTesting for molecular markers, including IDH variants and 1p/19q codeletion, is required for the classification of diffuse ...
  • Importantly if histological phenotype and genotype are not-concordant (e.g. looks like diffuse astrocytoma but is 1p19q co-deleted, ATRX-wildtype) then genotype wins, and it is used to determine diagnosis 3 . (radiopaedia.org)
  • Primary pulmonary artery sarcoma: diagnosis with CT, MR imaging, and transthoracic needle biopsy. (blogspot.com)
  • Among the autopsies on black Americans there were no cases of opportunistic infections or Kaposi's sarcoma that were considered to be consistent with the AIDS. (nih.gov)
  • In 27% of diffuse large B cell lymphoma (DLBCL) cases, bone marrow (BM), assessed by BM biopsy, is involved. (springermedizin.de)
  • Zurück zum Zitat Campbell J, Seymour JF, Matthews J, Wolf M, Stone J, Juneja S (2006) The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement. (springermedizin.de)
  • Which medications in the drug class Antineoplastics, PI3K Delta Inhibitors are used in the treatment of Diffuse Large Cell Lymphoma? (medscape.com)
  • Hu CR, Wang JH, Wang R, Sun Q, Chen LB. Both FOXP1 and p65 expression are adverse risk factors in diffuse large B-cell lymphoma: a retrospective study in China. (medscape.com)
  • Analysis of the coding genome of diffuse large B-cell lymphoma. (medscape.com)
  • The initial evaluation of diffuse large B-cell lymphoma (DLBCL) patients is aimed at determining the stage of the disease, assessing for end-organ damage by the disease and/or preexisting comorbid conditions, and identifying situations that may affect treatment design. (medscape.com)
  • For example, high-dose chemotherapy in the setting of stem cell/bone marrow transplantation has become a useful treatment modality in the management of diffuse large cell lymphoma. (medscape.com)
  • A study by Kim et al determined that although the quality of life (QOL) of patients with intestinal diffuse large B-cell lymphoma who underwent surgery and chemotherapy was lower than that of patients who underwent chemotherapy alone, the difference was acceptable. (medscape.com)
  • Unless contraindicated because of significant and preexisting comorbid conditions, the treatment of diffuse large B-cell lymphoma (DLBCL) should include the use of rituximab- and anthracycline-based-multiagent chemotherapy, and the goal should be to achieve a durable complete remission (ie, cure). (medscape.com)
  • [ 73 ] and has activity in diffuse large cell lymphoma. (medscape.com)
  • A phase II pilot study of rituximab in combination with CHOP in patients with previously untreated diffuse large cell lymphoma or high-grade NHL reported an overall response rate of 97% (32 of 33 patients), with a 61% complete remission rate, a 36% partial remission rate, and a 3% progressive disease rate. (medscape.com)
  • In a study of 435 patients with diffuse large cell lymphoma, Villa et al found that the risk of CNS relapse was significantly reduced with the addition of rituximab to the CHOP regimen compared with risk reduction for patients treated with CHOP alone. (medscape.com)
  • Récher et al compared the efficacy of R-CHOP with that of treatment consisting of rituximab added to a regimen of doxorubicin, cyclophosphamide, vindesine, bleomycin, and prednisone (R-ACVBP) and found significant improvement in survival with the R-ACVBP regimen among patients aged 18-59 years with diffuse large B-cell lymphoma and low intermediate risk. (medscape.com)
  • At relapse, evidence suggests that the cell of origin has a better response to rituximab, dexamethasone, high-dose cytarabine, and cisplatin (R-DHAP) than to rituximab, ifosfamide, carboplatin, and etoposide (R-ICE) in patients with germinal center B (GCB)-like diffuse large B-cell lymphoma. (medscape.com)
  • Aberrant expression of CDK9/cyclin T1 has been found in diffuse large B-cell lymphoma, and suggest that CDK9 seems to be a potential therapeutic target for diffuse large B-cell lymphoma. (haematologica.org)
  • Here, we firstly demonstrated that CDKI-73, a novel CDK inhibitor, potently blocks CDK9, triggered apoptosis and dramatically repressed diffuse large B-cell lymphoma cell growth owing to CDK9 inhibition. (haematologica.org)
  • Cells with characteristics of diffuse large B cell lymphoma often occupied expanded splenic follicles and lymph nodes. (aacrjournals.org)
  • Submit your Twitter account related to Diffuse Large B-cell Lymphoma to be featured! (novusbio.com)
  • Submit your blog on Diffuse Large B-cell Lymphoma to be featured! (novusbio.com)
  • The study of Diffuse Large B-cell Lymphoma has been mentioned in research publications which can be found using our bioinformatics tool below. (novusbio.com)
  • Researched pathways related to Diffuse Large B-cell Lymphoma include Pathogenesis, Localization, Cell Cycle, Cell Proliferation, Cell Death. (novusbio.com)
  • These pathways complement our catalog of research reagents for the study of Diffuse Large B-cell Lymphoma including antibodies and ELISA kits against ANAPLASTIC LYMPHOMA KINASE, CD3, ALK, BCL2, BCL6. (novusbio.com)
  • Explore more on Diffuse Large B-cell Lymphoma below! (novusbio.com)
  • We have 3690 products for the study of Diffuse Large B-cell Lymphoma that can be applied to Chromatin Immunoprecipitation, Flow Cytometry, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits. (novusbio.com)
  • Diffuse Large B-cell Lymphoma is also known as diffuse large b-cell lymphoma, lymphoma, diffuse large b-cell, large b cell diffuse lymphoma, lymphoma. (novusbio.com)
  • 3132, originally classified as a B-cell lymphoma, was reclassified as a histiocytic sarcoma based on characteristic cytogenomic properties. (biomedcentral.com)
  • Sarcomas metastatic to the lung outnumber primary pulmonary sarcomas and, depending on one's index of suspicion, the pathologist may need to take a more active role in prompting clinical colleagues to consider an occult or remote soft tissue primary. (redorbit.com)